Cell BiologyeLifePeer-reviewed
Chemotherapy activates inflammasomes to cause inflammation-associated bone loss
Chun Wang, Khushpreet Kaur, Canxin Xu…·Gabriel Mbalaviele
This study shows doxorubicin causes bone loss via inflammasome activation, leading to pyroptosis and NETosis, and identifies AIM2 and NLRP3 as key mediators.
23 citations